tiprankstipranks
Asymchem Laboratories (Tianjin) Co., Ltd. Class H (HK:6821)
:6821
Hong Kong Market
6821
Asymchem Laboratories (Tianjin) Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:6821 full AI Analyst Report?

Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

6821 Analyst Ratings

Strong Buy
6Ratings
Strong Buy
5 Buy
1 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Asymchem
Laboratories (Tianjin) Co., Ltd. Class H
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

6821 Stock 12 Month Forecast

Average Price Target

HK$127.54
▲(72.82% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Asymchem Laboratories (Tianjin) Co., Ltd. Class H in the last 3 months. The average price target is HK$127.54 with a high forecast of HK$136.60 and a low forecast of HK$115.43. The average price target represents a 72.82% change from the last price of HK$73.80.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"53":"HK$53","74":"HK$74","95":"HK$95","116":"HK$116","137":"HK$137"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":136.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$136.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":127.54333333333334,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$127.54</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":115.43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$115.43</span>\n  </div></div>","useHTML":true}}],"tickPositions":[53,74,95,116,137],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,105.4,107.80000000000001,110.2,112.60000000000001,115,117.4,119.8,122.2,124.6,127,129.4,131.79999999999998,134.2,{"y":136.6,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,105.4,107.10333333333334,108.80666666666667,110.51,112.21333333333334,113.91666666666667,115.62,117.32333333333334,119.02666666666667,120.73,122.43333333333334,124.13666666666667,125.84,{"y":127.54333333333334,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,105.4,106.17153846153846,106.94307692307693,107.71461538461539,108.48615384615385,109.25769230769231,110.02923076923078,110.80076923076923,111.5723076923077,112.34384615384616,113.11538461538463,113.88692307692308,114.65846153846155,{"y":115.43,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":54.21,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.79,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.7,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":101.7,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.05,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.65,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.7,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.8,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.2,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":78,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":76.1,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.5,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.4,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$136.60Average Price TargetHK$127.54Lowest Price TargetHK$115.43
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CLSA Analyst forecast on HK:6821
Unknown Analyst
CLSA
Not Ranked
CLSA
HK$128.2
Buy
73.71%
Upside
Reiterated
04/29/26
Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821) Gets a Buy from CLSA
BOCOM International Holdings Company Analyst forecast on HK:6821
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
HK$123.2→HK$136.6
Buy
85.09%
Upside
Reiterated
04/29/26
BOCOM International Holdings Company Reaffirms Their Buy Rating on Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821)
Huatai Securities Analyst forecast on HK:6821
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$129.44
Buy
75.39%
Upside
Reiterated
04/28/26
Huatai Securities Keeps Their Buy Rating on Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821)
CMBC International Analyst forecast on HK:6821
Unknown Analyst
CMBC International
Not Ranked
CMBC International
HK$135.59
Buy
83.73%
Upside
Reiterated
04/17/26
CMBC International Reaffirms Their Buy Rating on Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821)
Morgan Stanley Analyst forecast on HK:6821
Laurence Tam
Morgan Stanley
Morgan Stanley
HK$114→HK$120
Hold
62.60%
Upside
Reiterated
04/15/26
Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821) Receives a Hold from Morgan Stanley
Nomura Analyst forecast on HK:6821
Unknown Analyst
Nomura
Not Ranked
Nomura
HK$115.43
Buy
56.41%
Upside
Reiterated
03/31/26
Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821) Gets a Buy from Nomura
Goldman Sachs Analyst forecast on HK:6821
Ziyi Chen
Goldman Sachs
Goldman Sachs
HK$106.3→HK$98.4
Buy
33.33%
Upside
Reiterated
10/31/25
Macquarie Analyst forecast on HK:6821
Tony Ren
Macquarie
Macquarie
HK$123
Buy
66.67%
Upside
Reiterated
09/08/25
Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821) Gets a Buy from Macquarie
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CLSA Analyst forecast on HK:6821
Unknown Analyst
CLSA
Not Ranked
CLSA
HK$128.2
Buy
73.71%
Upside
Reiterated
04/29/26
Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821) Gets a Buy from CLSA
BOCOM International Holdings Company Analyst forecast on HK:6821
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
HK$123.2→HK$136.6
Buy
85.09%
Upside
Reiterated
04/29/26
BOCOM International Holdings Company Reaffirms Their Buy Rating on Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821)
Huatai Securities Analyst forecast on HK:6821
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$129.44
Buy
75.39%
Upside
Reiterated
04/28/26
Huatai Securities Keeps Their Buy Rating on Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821)
CMBC International Analyst forecast on HK:6821
Unknown Analyst
CMBC International
Not Ranked
CMBC International
HK$135.59
Buy
83.73%
Upside
Reiterated
04/17/26
CMBC International Reaffirms Their Buy Rating on Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821)
Morgan Stanley Analyst forecast on HK:6821
Laurence Tam
Morgan Stanley
Morgan Stanley
HK$114→HK$120
Hold
62.60%
Upside
Reiterated
04/15/26
Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821) Receives a Hold from Morgan Stanley
Nomura Analyst forecast on HK:6821
Unknown Analyst
Nomura
Not Ranked
Nomura
HK$115.43
Buy
56.41%
Upside
Reiterated
03/31/26
Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821) Gets a Buy from Nomura
Goldman Sachs Analyst forecast on HK:6821
Ziyi Chen
Goldman Sachs
Goldman Sachs
HK$106.3→HK$98.4
Buy
33.33%
Upside
Reiterated
10/31/25
Macquarie Analyst forecast on HK:6821
Tony Ren
Macquarie
Macquarie
HK$123
Buy
66.67%
Upside
Reiterated
09/08/25
Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821) Gets a Buy from Macquarie
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Asymchem Laboratories (Tianjin) Co., Ltd. Class H

3 Months
Jialin ZhangNomura
Success Rate
3/8 ratings generated profit
38%
Average Return
+4.91%
Copying Jialin Zhang's trades and holding each position for 3 Months would result in 37.50% of your transactions generating a profit, with an average return of +4.91% per trade.
1 Year
Ziyi ChenGoldman Sachs
Success Rate
2/3 ratings generated profit
67%
Average Return
-4.07%
Copying Ziyi Chen's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -4.07% per trade.
2 Years
Ziyi ChenGoldman Sachs
Success Rate
2/3 ratings generated profit
67%
Average Return
-9.60%
Copying Ziyi Chen's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of -9.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

6821 Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
0
0
1
6
6
Hold
0
0
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
1
7
7
In the current month, 6821 has received 6 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 6821 average Analyst price target in the past 3 months is 127.54.
Each month's total comprises the sum of three months' worth of ratings.

6821 Financial Forecast

6821 Earnings Forecast

Next quarter’s earnings estimate for 6821 is HK$0.00 with a range of HK$0.00 to HK$0.00. The previous quarter’s EPS was HK$0.96. 6821 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 6821 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 6821 is HK$0.00 with a range of HK$0.00 to HK$0.00. The previous quarter’s EPS was HK$0.96. 6821 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 6821 has Performed in-line its overall industry.

6821 Sales Forecast

Next quarter’s sales forecast for 6821 is HK$2.24B with a range of HK$2.24B to HK$2.24B. The previous quarter’s sales results were HK$2.03B. 6821 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 6821 has Performed in-line its overall industry.
Next quarter’s sales forecast for 6821 is HK$2.24B with a range of HK$2.24B to HK$2.24B. The previous quarter’s sales results were HK$2.03B. 6821 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 6821 has Performed in-line its overall industry.

6821 Stock Forecast FAQ

What is HK:6821’s average 12-month price target, according to analysts?
Based on analyst ratings, Asymchem Laboratories (Tianjin) Co., Ltd. Class H’s 12-month average price target is 127.54.
    What is HK:6821’s upside potential, based on the analysts’ average price target?
    Asymchem Laboratories (Tianjin) Co., Ltd. Class H has 72.82% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Asymchem Laboratories (Tianjin) Co., Ltd. Class H a Buy, Sell or Hold?
          Asymchem Laboratories (Tianjin) Co., Ltd. Class H has a consensus rating of Strong Buy, which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Asymchem Laboratories (Tianjin) Co., Ltd. Class H’s share price target?
            The average share price target for Asymchem Laboratories (Tianjin) Co., Ltd. Class H is 127.54. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$136.60 ,and the lowest forecast is HK$115.43. The average share price target represents 72.82% Increase from the current price of HK$73.8.
              What do analysts say about Asymchem Laboratories (Tianjin) Co., Ltd. Class H?
              Asymchem Laboratories (Tianjin) Co., Ltd. Class H’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of Asymchem Laboratories (Tianjin) Co., Ltd. Class H?
                To buy shares of HK:6821, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.